Share Name Share Symbol Market Type Share ISIN Share Description
Dunedin Income Growth Investment Trust Plc LSE:DIG London Ordinary Share GB0003406096 ORD 25P
  Price Change % Change Share Price Shares Traded Last Trade
  0.50 0.16% 316.00 156,723 16:35:29
Bid Price Offer Price High Price Low Price Open Price
317.00 318.00 318.00 316.00 316.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 18.35 16.16 10.90 29.0 470
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:29 UT 739 316.00 GBX

Dunedin Income Growth In... (DIG) Latest News (1)

More Dunedin Income Growth In... News
Dunedin Income Growth In... Investors    Dunedin Income Growth In... Takeover Rumours

Dunedin Income Growth In... (DIG) Discussions and Chat

Dunedin Income Growth In... (DIG) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Dunedin Income Growth In... trades in real-time

Dunedin Income Growth In... (DIG) Top Chat Posts

Dunedin Income Growth In... Daily Update: Dunedin Income Growth Investment Trust Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker DIG. The last closing price for Dunedin Income Growth In... was 315.50p.
Dunedin Income Growth Investment Trust Plc has a 4 week average price of 308p and a 12 week average price of 304p.
The 1 year high share price is 323p while the 1 year low share price is currently 241p.
There are currently 148,784,898 shares in issue and the average daily traded volume is 205,254 shares. The market capitalisation of Dunedin Income Growth Investment Trust Plc is £470,160,277.68.
lurker: I know...I love this share...still my favourite IT amongst the many I hold
goldpiguk: Hi panshanger1, Good to see the 2nd interim dividend maintained at 3p a share, to be paid on 27th November to shareholders on the register on 6th November. Earnings per share have fallen but still above 6p for the first half. A great core holding in any IT portfolio. Goldpig
ec2: Very pleasing half year numbers today. 6% NAV total return outperformance over the FTSE All Share. Div payout maintained and fully covered giving a 5% yield. Well done to the managers.
speedsgh: First Interim Dividend - HTTPS:// The Board has today declared a first interim dividend in respect of the year ending 31 January 2021, of 3.0p per share, which will be payable on 28 August 2020 to shareholders on the register on 7 August 2020, with an ex-dividend date of 6 August 2020. As has been widely reported, the impact of COVID-19 has seen a large number of companies suspending or cancelling their dividends, including some held within the Company's portfolio. There are many factors that will impact the speed with which those dividends will begin to resume, and at what rate, and that outlook is far from clear. It seems highly likely, therefore, that the Company's total dividends for the current year will not be covered by net revenue received. As shareholders are aware, however, the Company had revenue reserves at 31 January 2020 equivalent to 10.94p per share accrued from excess net revenue earned in earlier years, representing 86% of the current annual dividend cost. Future dividend decisions will be made based on the circumstances at the time, taking into account both dividend receipts and revenue reserves, but the Company's dividend policy remains to grow the dividend faster than the rate of inflation over the medium term.
goldpiguk: Hi, Final results were very much in line with what I had expected. Although EPS have fallen a little to 12.08p a share, the final dividend has been raised to 3.7p, payable on 29th May to shareholders on the register on 11th May. Total dividend for the year is 12.7p. After payment of the Q4 dividend revenue reserves will be 10.94p a share. The drop in eps was well flagged in advance, so this year the total dividend is not fully covered. Even if eps fall further this year (as I would expect, because of the coronavirus,) the trust looks well placed to maintain dividends until this crisis is over. Goldpig
goldpiguk: Hi panshanger1, I have just completed building my holding in DIG, with a small purchase on Monday, bringing my total to 20,000 shares. In the short term Coronavirus threatens all investments and I expect a very volatile period over coming months. Some market analysts interviewed on Bloomberg think a further 15% fall in the DOW is on the cards, so, short term further falls in the UK seem likely. I hold all IT's in my ISA for the long term. Market value of my DIG investment is still well above average purchase price as are my other IT holdings, HFEL and MRCH. In April I will start building a new position in another Investment Trust; and given market volatility will most likely drip feed money into my ISA. I have a couple of IT's I am following closely with a view to making an initial purchase. My decision will depend on market conditions. Goldpig
ec2: Have done well in these but have today also bought some EDIN as I think this trust looks undervalued in comparison to other UK Equity Income Trusts. The depressed EDIN share price owing to the poor performing, but now to be replaced, asset Mgr creates an opportunity to get into a spread of big dividend hitting UK Equities on the cheap when other similar UK trusts are now on very narrow discounts. The 11% disc and 4.5% yield looks compelling. The 1.65 years of income cover in the income reserve also gives an unrivalled level of comfort for future income distributions. Still keeping my DIG for the income as well but they have had a good run. Hoping EDIN will generate capital growth in addition to the income as the discount moves into line with similar trusts.
panshanger1: It's a golden oldie no doubt but performing better under a new manager who has reorganised the portfolio over the last 2 years ? Feels like FYI :you'll see further comments on DIG recently on the merchants trust board
goldpiguk: Hi EssentialInvestor, I too have added a few in recent weeks using ISA dividends. The shares may well spike up on results, but the direction of travel looks certain to be dominated by Brexit progress, or more likely lack of it. I am building my position here and hope to add gradually over the coming months on price dips, drip feeding money into DIG rather than making a large ISA share purchase, which I usually do when building my position in a company at the start of the new tax year. Goldpig
speedsgh: from Fund Manager's Report in the latest Factsheet to 31/7/2018... The major share price movements within the portfolio were once again due to company specific events. French employee benefit and payments business Edenred increased sharply on the back of a very positive set of interim results, demonstrating the benefit of our overseas positioning in generating diverse and attractive investment opportunities. UK listed small cap life insurer Chesnara rebounded sharply on a broker upgrade that highlighted the significant discount to net assets and the attractive and growing dividend. Not owning Glencore also proved beneficial as the miner was hit by a potential US Department of Justice investigation into its conduct in a number of emerging markets. At a sector level oil companies lagged as hydrocarbon prices fell following a strong run since the start of the year amidst some concerns over rising US output. In contrast tobacco stocks continued to perform strongly, benefiting from solid results and a stronger dollar, partially reversing some of the very significant underperformance of the past twelve months. Pharmaceutical stocks also performed well primarily led by growing investor enthusiasm for AstraZeneca and their attractive revenue profile from new products. Activity remained relatively high as we continued to shift the portfolio towards better quality, higher growth and smaller companies. As a result we introduced new holdings in life sciences company Abcam and financial services provider London Stock Exchange. Both of these are lower yielding investments but offer the prospect of double digit dividend growth for many years ahead. Abcam is a world leading franchise specialising in the manufacture and distribution of antibodies used in scientific research. It has exceptional long–term growth prospects, a strong balance sheet and the potential to significantly increase their distributions to shareholders over time. London Stock Exchange has a very strong position in the provision of exchange, clearing, index and settlement services. This provides high and resilient levels of growth that should translate into attractive levels of dividend growth to its investors. We added further to positions in a number of mid-sized companies including Hansteen which owns a high yielding portfolio of industrial real estate, Assura the provider of primary care facilities across the UK and Aveva the leading design software provider for oil and gas, power and marine industries. At the larger end of the market cap spectrum we also increased our holding further in British American Tobacco, attracted by the elevated yield and resilient growth and National Grid where strong performance in their US assets increasingly underpins the high and steadily growing dividend. We trimmed our position in Experian given a stretched valuation following a significant increase in the share price on the back of positive results. We also exited our relatively small position in Swiss pharmaceutical giant Roche given lacklustre prospects for dividend growth and reduced our holding in HSBC where the growth outlook is also subdued and the yield no longer offers such an attractive premium to that achievable elsewhere. Our approach remains unchanged and we continue to focus on improving the medium term income and capital growth potential of the portfolio while maintaining appropriate diversity and balancing the near term requirements of our relatively high yield. Benefiting from the new combined research capabilities of the firm we have an increasingly full pipeline of attractive potential investments, particularly those focused toward capital and income growth. Finding higher yielding companies that we deem of sufficient quality for long-term investment is more challenging but we continue to evaluate a number of opportunities. All of which should allow us to position the portfolio in an increasingly differentiated manner, while underpinning the dividend policy. Equity markets remain relatively buoyant although there are a number of headwinds developing, particularly around global trade and the increasingly bellicose approach of the US to the implementation of sanctions on countries such as Turkey. As such we see little reason to shift from a conservative focus on higher quality businesses. While significant movements in large benchmark weighted stocks can affect near term relative performance, given changes to the portfolio and sound corporate performance we remain confident in the total return potential for the trust.
Dunedin Income Growth In... share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Dunedin In..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210729 19:32:53